Search

Search Constraints

You searched for: Author/Creator Hock, Christoph

Search Results

1. [IC‐P‐018]: NEUROIMAGING‐DEFINED AMYLOID AND CEREBROVASCULAR PATHOLOGY ARE ASSOCIATED WITH A NEUROMETABOLIC SIGNATURE OF ALZHEIMER's DISEASE. (1st July 2017)

2. O1‐09‐06: 24‐MONTH ANALYSIS OF CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB. (1st July 2006)

3. P1‐040: Clinical Dementia Rating‐Sum of Boxes Responder Analysis in Prime: A Randomized Phase 1B Study of the Anti‐Amyloid Beta Monoclonal Antibody Aducanumab (BIIB037). (1st July 2016)

5. [P1–053]: CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME, A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037). (1st July 2017)

6. P1‐041: 24‐MONTH ANALYSIS OF APOE ε4 CARRIERS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB. (1st July 2006)

7. P3‐225: POSTERIOR CINGULATE GABA AND GLX ARE REDUCED IN AMNESTIC MILD COGNITIVE IMPAIRMENT. (1st July 2014)

8. GABA and glutamate associate with evidence of preclinical Alzheimer disease in humans: A 7 Tesla MRSI and 11C‐PIB PET study: Neuroimaging / Optimal neuroimaging measures for early detection. (7th December 2020)

9. Reduced uptake of [11C]‐ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer's dementia. Issue 6 (18th April 2020)

10. Lifestyle Affects Amyloid Burden and Cognition Differently in Men and Women. Issue 3 (14th June 2022)